{"id":1444,"date":"2019-04-29T21:32:26","date_gmt":"2019-04-29T18:32:26","guid":{"rendered":"http:\/\/blog.ulubat.org\/?p=1444"},"modified":"2019-04-29T21:32:28","modified_gmt":"2019-04-29T18:32:28","slug":"hiv-aids-ve-gelecegi","status":"publish","type":"post","link":"https:\/\/blog.ulubat.org\/index.php\/populer-tip\/hiv-aids-ve-gelecegi\/","title":{"rendered":"HIV\/AIDS VE GELECE\u011e\u0130"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>    Ge\u00e7ti\u011fimiz yirmi y\u0131lda yakla\u015f\u0131k 65 milyon ki\u015finin AIDS oldu\u011fu ve bu gruptaki insanlar\u0131n yakla\u015f\u0131k 25 milyonunun hayat\u0131n\u0131 kaybetti\u011fi bilinen ac\u0131 bir ger\u00e7ek. Her ko\u015fulda \u00f6l\u00fcmc\u00fcl olan AIDS felaketini \u015fu anda tam anlam\u0131yla tedavi edebilmek m\u00fcmk\u00fcn de\u011fil. Fakat AIDS i\u00e7in g\u00fcn\u00fcm\u00fczde uygulanan ve gelecekte uygulanacak olan  tedavileri anlamam\u0131z i\u00e7in baz\u0131 noktalar\u0131n \u00fczerinde k\u0131saca durmam\u0131z gerekiyor.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p style=\"text-align:center\" class=\"has-background has-very-light-gray-background-color\"><strong>HIV Nedir? AIDS Nedir? \u0130kisi Ayn\u0131 Anlama M\u0131 Geliyor?<\/strong><\/p>\n\n\n\n<p>    HIV v\u00fccudumuzun do\u011fal savunma mekanizmas\u0131 olan &#8220;\u0130mm\u00fcn Sistemi&#8221;mize sald\u0131ran  bir vir\u00fcst\u00fcr. HIV bunu  \u0130mm\u00fcn Sistem&#8217;in \u00f6nemli bir par\u00e7as\u0131 olan yard\u0131mc\u0131 T H\u00fccrelerinin i\u00e7inde kendi kopyalar\u0131n\u0131 \u00fcreterek ba\u015far\u0131r. HIV yard\u0131mc\u0131 T H\u00fccrelerinde kopyalar\u0131n\u0131 \u00fcrettik\u00e7e, ki\u015finin ba\u011f\u0131\u015f\u0131kl\u0131k sistemini zay\u0131flatmaya ba\u015flar. Tedavi edilmedi\u011fi takdirde, a\u015f\u0131r\u0131 zay\u0131flayan ba\u011f\u0131\u015f\u0131kl\u0131k sistemi v\u00fccudu savunmas\u0131z bir konuma getirir ve ki\u015fi uzun y\u0131llar sonra hayat\u0131n\u0131 kaybedebilir.<\/p>\n\n\n\n<p>   AIDS (Edinilmi\u015f Ba\u011f\u0131\u015f\u0131kl\u0131k Eksikli\u011fi Sendromu)  HIV&#8217;den kaynaklanan semptom k\u00fcmesidir. HIV ta\u015f\u0131yan birine AIDS diyebilmemiz i\u00e7in o ki\u015finin ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin en basit bir enfeksiyonla bile m\u00fccadele edememesi gerekir. HIV&#8217;in son evresi olan AIDS&#8217;te, enfeksiyon tedavi edilmezse \u00f6l\u00fcm ka\u00e7\u0131n\u0131lmazd\u0131r. Bu a\u00e7\u0131klamalardan da anlayaca\u011f\u0131m\u0131z \u00fczere her HIV ta\u015f\u0131yan AIDS de\u011fildir.<\/p>\n\n\n\n<p style=\"text-align:center\" class=\"has-background has-very-light-gray-background-color\"><strong>TEDAV\u0130S\u0130 M\u00dcMK\u00dcN M\u00dc? GELECEKTE B\u0130ZLER\u0130 NELER BEKL\u0130YOR?<\/strong><\/p>\n\n\n\n<p>    HIV&#8217;i kesin bir \u015fekilde tedavi etmek \u015fu anda m\u00fcmk\u00fcn de\u011fil.Ama &#8220;ART&#8221; diye tabir edilen ila\u00e7 tedavisiyle HIV&#8217;i bask\u0131lamak m\u00fcmk\u00fcn. HIV tedavilerinde v\u00fccudu HIV&#8217;den tamamen ar\u0131nd\u0131rma noktas\u0131na hen\u00fcz gelinemedi. Fakat ART y\u00f6ntemiyle vir\u00fcs\u00fc ta\u015f\u0131yan birey, sanki hi\u00e7 vir\u00fcs ta\u015f\u0131m\u0131yormu\u015f gibi ya\u015fam\u0131n\u0131 s\u00fcrd\u00fcrebilir<br>      HIV&#8217;i bask\u0131layabilmek i\u00e7in ilk gereken \u015fey ki\u015finin HIV ta\u015f\u0131d\u0131\u011f\u0131n\u0131n bilinmesidir. Fakat Ki\u015fi HIV ta\u015f\u0131d\u0131\u011f\u0131n\u0131 y\u0131llarca anlamayabilir, y\u0131llar boyu semptom g\u00f6zlenmeyebilir ve ki\u015fi HIV&#8217;in son evresinde oldu\u011funda yani AIDS oldu\u011funda HIV ta\u015f\u0131d\u0131\u011f\u0131n\u0131 anlayabilir. Bu y\u00fczden hastay\u0131 tedavi etmek zorla\u015fabilir.<br>     Bundan 10 y\u0131l \u00f6nce bir HIV ta\u015f\u0131yan bir l\u00f6semi hastas\u0131na, do\u011fal olarak HIV&#8217;e kar\u015f\u0131 diren\u00e7li olan bir don\u00f6r\u00fcn kemik ili\u011fi nakledildi ve bu ki\u015fi insanl\u0131k tarihinde tam anlam\u0131yla HIV&#8217;den ar\u0131nan ilk ki\u015fi oldu. Fakat bu y\u00f6ntemi her HIV olan ki\u015fiye uygulayamazd\u0131n\u0131z. \u00c7\u00fcnk\u00fc, bahsedilen tedavi y\u00f6ntemi primer olarak l\u00f6semiyi ortadan kald\u0131rmak i\u00e7in uygulanm\u0131\u015ft\u0131. Bu y\u00fczden \u015fimdilik de olsa, HIV&#8217;i tamamen tedavi etmek pek de m\u00fcmk\u00fcn de\u011fil.<br>   <\/p>\n\n\n\n<p>Fakat bilim d\u00fcnyas\u0131 HIV&#8217;i ortadan kald\u0131rmak i\u00e7in \u00e7al\u0131\u015fmalar\u0131n\u0131 s\u00fcrd\u00fcrmektedir. Bilim insanlar\u0131n\u0131n  \u00fczerinde  \u00e7al\u0131\u015ft\u0131\u011f\u0131 baz\u0131 metodlar\u0131 burada k\u0131saca a\u00e7\u0131klayacak olursak,<\/p>\n\n\n\n<ol><li>HIV Replikasyonunu inhibe etmek:  ABX464 olarak adland\u0131r\u0131lan bir ila\u00e7, vir\u00fcs RNA&#8217;s\u0131n\u0131n  spesifik bir dizisine ba\u011flan\u0131p \u00e7o\u011falmas\u0131n\u0131 \u00f6nler. Faz 2a \u00e7al\u0131\u015fmas\u0131nda,antiretroviral tedaviye ek olarak  birka\u00e7 hastaya ila\u00e7 verildi. ABX464 ile tedavi edilen 15 hastan\u0131n sekizinde, 28 g\u00fcn sonra HIV rezervuarlar\u0131nda % 25 ile % 50 aras\u0131nda azalma g\u00f6zlemlenmi\u015ftir, bununla birlikte sadece antiretroviral tedavi alanlarda herhangi bir azalma g\u00f6r\u00fclmemi\u015ftir.<\/li><li>\u0130mm\u00fcnoterapi: Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerine sald\u0131ran HIV&#8217;in, Ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin g\u00fc\u00e7lendirlmesiyle yok edilmesine dayal\u0131 bir tedavi y\u00f6ntemi.<\/li><li>Gen Terapisi: D\u00fcnya n\u00fcfusunun yakla\u015f\u0131k %1&#8217;inin HIV&#8217;e kar\u015f\u0131 do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131k kazanm\u0131\u015f oldu\u011fu d\u00fc\u015f\u00fcn\u00fcl\u00fcyor. Bunun sebebi ise, ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin y\u00fczeyindeki bir proteinin mutasyona u\u011fram\u0131\u015f olmas\u0131 ve buna ba\u011fl\u0131 olarak HIV&#8217;in h\u00fccre i\u00e7ine girememesidir. Gen terapisiyle birlikte,  DNA&#8217;y\u0131 d\u00fczenlemek ve HIV&#8217;i durdurmak i\u00e7in bu mutasyonu tan\u0131tmak m\u00fcmk\u00fcn olaca\u011f\u0131 m\u00fcmk\u00fcn gibi g\u00f6z\u00fckmektedir.<\/li><\/ol>\n\n\n\n<p> \u015eimdiye kadar, bu fonksiyonel tedavilerin hi\u00e7biri klinik testlerde son ad\u0131ma kadar gelemedi, bu durum 2020&#8217;ye kadar HIV&#8217;i tamamen tedavi etmenin m\u00fcmk\u00fcn olmad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Ama, 2020 y\u0131l\u0131 b\u00fcy\u00fck ihtimalle  \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 olacak.Klinik testlerin son ad\u0131m\u0131  o y\u0131l uygulanmaya ba\u015flanacak.Bu y\u00f6ntemlerden herhangi biri ba\u015far\u0131 g\u00f6sterdi\u011fi takdirde 10 y\u0131l i\u00e7inde HIV tedavisi onaylanm\u0131\u015f olackat\u0131r.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><strong>KAYNAKLAR:<\/strong><\/p>\n\n\n\n<ol><li>https:\/\/www.foreignaffairs.com\/articles\/asia\/2002-11-01\/future-aids<\/li><li>http:\/\/www.gbchealth.org\/the-future-of-aids-leading-experts-reflect-on-progress-and-challenges-in-defeating-aids\/<\/li><li>https:\/\/medlineplus.gov\/magazine\/issues\/summer09\/articles\/summer09pg10.html<\/li><li>https:\/\/www.niaid.nih.gov\/diseases-conditions\/future-hiv-treatment<\/li><li>https:\/\/witanworld.com\/blog\/2019\/02\/10\/future-of-aids-treatment\/<\/li><li>https:\/\/www.newscientist.com\/article\/mg23731710-100-the-future-of-hiv\/<\/li><li>https:\/\/www.esquire.com\/lifestyle\/health\/a50742\/aids-eradication\/<\/li><li>https:\/\/www.avert.org\/about-hiv-aids\/what-hiv-aids<\/li><li>https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28474549<\/li><li> <a href=\"https:\/\/labiotech.eu\/features\/hiv-cure-2020-research-review\/\">https:\/\/labiotech.eu\/features\/hiv-cure-2020-research-review\/<\/a> <\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Ge\u00e7ti\u011fimiz yirmi y\u0131lda yakla\u015f\u0131k 65 milyon ki\u015finin AIDS oldu\u011fu ve bu gruptaki insanlar\u0131n yakla\u015f\u0131k 25 milyonunun hayat\u0131n\u0131 kaybetti\u011fi bilinen ac\u0131<\/p>\n","protected":false},"author":52,"featured_media":1446,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[19],"tags":[155,157,158,156,160,84,159],"acf":[],"views":1150,"_links":{"self":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/1444"}],"collection":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/comments?post=1444"}],"version-history":[{"count":1,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/1444\/revisions"}],"predecessor-version":[{"id":1447,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/posts\/1444\/revisions\/1447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/media\/1446"}],"wp:attachment":[{"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/media?parent=1444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/categories?post=1444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ulubat.org\/index.php\/wp-json\/wp\/v2\/tags?post=1444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}